Corcept Therapeutics (CORT) Change in Account Payables (2010 - 2026)
Corcept Therapeutics (CORT) reported Change in Account Payables of -$7.6 million for Q1 2026, down 160.81% on a YoY basis from $12.6 million in Q1 2025, and down 227.44% sequentially from $6.0 million in Q4 2025.
Corcept Therapeutics (CORT) Change in Account Payables (2010 - 2026) Analysis & Trends
Corcept Therapeutics (CORT) has 17 years of Change in Account Payables data on file, last reported at -$7.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 160.81% year-over-year to -$7.6 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (down 68.51% YoY), and the FY2025 full-year result was $25.1 million, up 1340.99% from the prior year.
- Change in Account Payables fell to -$7.6 million in Q1 2026, from $6.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $12.6 million in Q1 2025 to a low of -$7.6 million in Q1 2026.
- A 5-year average of $1.5 million and a median of -$165000.0 in 2022 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables jumped 5303.03% in 2023 and plunged 649.0% in 2024, its largest moves.
- Tracing CORT's Change in Account Payables over 5 years: stood at $4.2 million in 2022, then plunged by 84.98% to $637000.0 in 2023, then sank by 587.6% to -$3.1 million in 2024, then jumped by 293.11% to $6.0 million in 2025, then sank by 227.44% to -$7.6 million in 2026.
- Business Quant data shows CORT's Change in Account Payables at -$7.6 million in Q1 2026, $6.0 million in Q4 2025, and $10.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Corcept Therapeutics | 10.09 Bn | 9.76 Bn | 162.02 Mn | -7.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.64 Mn |
| Mar 31, 2026 | -7.64 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 10.92 Mn |
| Sep 30, 2025 | 10.92 Mn |
| Jun 30, 2025 | -4.42 Mn |
| Jun 30, 2025 | -4.42 Mn |
| Mar 31, 2025 | 12.57 Mn |
| Mar 31, 2025 | 12.57 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Sep 30, 2024 | -649,000.00 |
| Sep 30, 2024 | -649,000.00 |
| Jun 30, 2024 | 6.60 Mn |
| Jun 30, 2024 | 6.60 Mn |
| Mar 31, 2024 | -4.86 Mn |
| Mar 31, 2024 | -4.86 Mn |
| Dec 31, 2023 | 637,000.00 |
| Dec 31, 2023 | 637,000.00 |